PANCREATIC CANCER, ADULT
Clinical trials for PANCREATIC CANCER, ADULT explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADULT trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new drug cocktail targets tough pancreatic cancer
Disease control Not yet recruitingThis phase 2 trial tests whether adding nimotuzumab, a targeted antibody, to standard chemotherapy can help people with high-risk pancreatic cancer that can still be surgically removed. About 156 participants will receive either the drug combo or a placebo before and after surger…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New imaging tracer could spot hidden cancers and fibrosis in one scan
Diagnosis Not yet recruitingThis study tests a new imaging tracer called [18F]FAPI-74, which attaches to a protein found on cells in tumors and scarred or inflamed tissue. Researchers want to see if it can show these areas more clearly than current scans. About 770 adults with various cancers or non-cancer …
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE1, PHASE2 • Sponsor: Martin Huellner • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC